Prevalence of different risk variables in type 1 and type 2 diabetics with maculopathy
| Variable | Type 1 diabetes | Type 2 diabetes |
| Age at manifestation (years) | ||
| 0–19 | 12.1 | |
| 20–39 | 19.7 | 29.4 |
| 40–59 | 18.7 | 25.0 |
| >60 | 11.5 | 9.3 |
| Diabetes duration (years) | ||
| 0–9 | 1.5 | 6.0 |
| 10–19 | 16.4 | 27.6 |
| 20–29 | 30.7 | 45.2 |
| >30 | 28.1 | 37.2 |
| HbA1c (%) | ||
| >6.5 | 15.3 | 19.1 |
| 6.5–8.0 | 14.7 | 23.3 |
| >8.0 | 15.1 | 23.5 |
| Hypertension | 25.2 (9.3) | 26.1 (3.3) |
| Nephropathy | 35.6 (14.3) | 43.2 (21.9) |
| Neuropathy | 31.4 (6.2) | 30.3 (10.5) |
| Tg >2.2 mmol/l | 21.9 (13.8) | 23.1 (23.1) |
| Chol >6.5 mmol/l | 26.0 (12.4) | 24.4 (22.2) |
The prevalence rates (%) for patients without maculopathy are given in parentheses for comparison.